UBS Group
TMO icon

UBS Group’s Thermo Fisher Scientific TMO Stock Holding History

UBS Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21B Buy
2,453,453
+130,110
+6% +$70.6M 0.18% 104
2025
Q4 		$1.35B Buy
2,323,343
+4,890
+0.2% +$2.77M 0.22% 74
2025
Q3 		$1.12B Sell
2,318,453
-87,496
-4% -$40.7M 0.18% 91
2025
Q2 		$976M Sell
2,405,949
-214,005
-8% -$89.5M 0.17% 100
2025
Q1 		$1.3B Buy
2,619,954
+189,283
+8% +$103M 0.24% 65
2024
Q4 		$1.26B Sell
2,430,671
-115,988
-5% -$63.8M 0.23% 70
2024
Q3 		$1.58B Buy
2,546,659
+50,816
+2% +$30.1M 0.34% 43
2024
Q2 		$1.38B Buy
2,495,843
+205,653
+9% +$118M 0.34% 44
2024
Q1 		$1.33B Buy
2,290,190
+191,876
+9% +$108M 0.33% 47
2023
Q4 		$1.11B Buy
2,098,314
+55,668
+3% +$26.9M 0.33% 52
2023
Q3 		$1.03B Sell
2,042,646
-65,347
-3% -$34.8M 0.36% 48
2023
Q2 		$1.1B Buy
2,107,993
+37,752
+2% +$20.4M 0.37% 48
2023
Q1 		$1.19B Buy
2,070,241
+187,629
+10% +$106M 0.44% 37
2022
Q4 		$1.04B Buy
1,882,612
+82,745
+5% +$43.8M 0.39% 48
2022
Q3 		$913M Sell
1,799,867
-115,382
-6% -$64.6M 0.4% 41
2022
Q2 		$1.04B Sell
1,915,249
-247,659
-11% -$136M 0.43% 33
2022
Q1 		$1.28B Buy
2,162,908
+41,987
+2% +$24.1M 0.43% 39
2021
Q4 		$1.42B Sell
2,120,921
-167,010
-7% -$104M 0.41% 37
2021
Q3 		$1.31B Sell
2,287,931
-10,592
-0.5% -$5.81M 0.41% 37
2021
Q2 		$1.16B Sell
2,298,523
-158,057
-6% -$74.6M 0.37% 45
2021
Q1 		$1.12B Sell
2,456,580
-264,486
-10% -$126M 0.37% 47
2020
Q4 		$1.27B Buy
2,721,066
+77,644
+3% +$36.4M 0.43% 39
2020
Q3 		$1.17B Sell
2,643,422
-189,620
-7% -$78.3M 0.44% 43
2020
Q2 		$1.03B Sell
2,833,042
-226,106
-7% -$75.8M 0.43% 46
2020
Q1 		$868M Sell
3,059,148
-317,285
-9% -$100M 0.41% 53
2019
Q4 		$1.1B Buy
3,376,433
+39,759
+1% +$12.1M 0.38% 53
2019
Q3 		$972M Sell
3,336,674
-170,464
-5% -$48.8M 0.37% 55
2019
Q2 		$1.03B Buy
3,507,138
+240,526
+7% +$66.2M 0.4% 49
2019
Q1 		$894M Sell
3,266,612
-76,006
-2% -$18.9M 0.37% 55
2018
Q4 		$748M Buy
3,342,618
+163,089
+5% +$38.3M 0.34% 61
2018
Q3 		$776M Buy
3,179,529
+98,989
+3% +$22.8M 0.31% 62
2018
Q2 		$638M Buy
3,080,540
+70,574
+2% +$15M 0.28% 73
2018
Q1 		$621M Buy
3,009,966
+12,780
+0.4% +$2.68M 0.27% 81
2017
Q4 		$569M Buy
2,997,186
+11,011
+0.4% +$2.11M 0.23% 98
2017
Q3 		$565M Sell
2,986,175
-26,191
-0.9% -$4.74M 0.26% 87
2017
Q2 		$526M Buy
3,012,366
+53,592
+2% +$9M 0.27% 81
2017
Q1 		$454M Buy
2,958,774
+53,311
+2% +$8.15M 0.25% 85
2016
Q4 		$410M Buy
2,905,463
+141,143
+5% +$20.8M 0.23% 100
2016
Q3 		$440M Buy
2,764,320
+128,683
+5% +$19.8M 0.26% 74
2016
Q2 		$389M Buy
2,635,637
+122,327
+5% +$18.1M 0.24% 85
2016
Q1 		$356M Buy
2,513,310
+5,844
+0.2% +$783K 0.24% 84
2015
Q4 		$356M Buy
2,507,466
+376,962
+18% +$50.3M 0.23% 90
2015
Q3 		$261M Buy
2,130,504
+191,170
+10% +$24.9M 0.18% 125
2015
Q2 		$252M Buy
1,939,334
+369,693
+24% +$48.2M 0.17% 144
2015
Q1 		$211M Buy
1,569,641
+516,568
+49% +$66.6M 0.15% 161
2014
Q4 		$132M Buy
+1,053,073
New +$128M 0.09% 231

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group's TMO Position: Q1 2026 in Review

UBS Group increased its Thermo Fisher Scientific (TMO) stake by 5.6% in Q1 2026, buying an estimated $70.6M and bringing the position to 2,453,453 shares worth $1.21B. The position accounts for 0.18% of the portfolio, ranked #104.

UBS Group first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.58B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • UBS Group held 2,453,453 shares of Thermo Fisher Scientific worth $1.21B as of Q1 2026.
  • UBS Group bought 130,110 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.6M.
  • Thermo Fisher Scientific made up 0.18% of UBS Group's portfolio in Q1 2026, its #104 holding.
  • UBS Group first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Thermo Fisher Scientific position peaked at $1.58B in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.